+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Progress in Molecular Biology and Translational Science, Vol 167

  • ID: 4768640
  • Book
  • 300 Pages
  • Elsevier Science and Technology
1 of 4

Progress in Molecular Biology and Translational Science, Volume 167 provides the most topical, informative and exciting monographs available on a wide variety of research topics related to Models and Biological Targets in Drug Discovery for Attention Deficit Hyperactivity Disorder, Novel Targets for Parkinson-Depression Co-morbidity. Utility of Cannabidiol (CBD) in Neuropsychiatric Disorders: A Short Review of the Recent Pre-clinical and Clinical Findings, The Many Sides of Microglia in Alcohol Use Disorders, Stress, Anxiety, Molecular Targets and More, Calcineurin Signaling in Psychiatric Disorders, Emerging Evidence for the Role of Pituitary Adenylate Cyclase- Activating Peptide (PACAP) in Neuropsychiatric Disorders, and more.

  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field
Note: Product cover images may vary from those shown
2 of 4
1. Models and biological targets in drug discovery for attention deficit hyperactivity disorder Linda Dwoskin 2. Novel Targets for Parkinson-Depression Co-morbidity Yousef Tizabi 3. Utility of Cannabidiol (CBD) in Neuropsychiatric Disorders: A Short Review of the Recent Pre-clinical and Clinical Findings Bernard Le Foll 4. The many sides of microglia in alcohol use disorders Kim Nixon 5. Stress, Anxiety, Molecular Targets and More Samina Salim 6. Calcineurin Signaling in Psychiatric Disorders Patrick Ronan 7. Emerging evidence for the role of Pituitary adenylate cyclase- activating peptide (PACAP) in neuropsychiatric disorders Kabirullah Lutfy 8. Glial and neuroinflammatory targets in major depressive disorder-a road to novel therapeutics Shafiqur Rahman 9. Calpain in the Cleavage of Alpha-synuclein and the Pathogenesis of Parkinson's Disease Azizul Haque 10. The role of glia in the pathogenesis of autism spectrum disorders Ryuta Koyama
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Teplow, David B.
Professor Teplow is a member of the Department of Neurology, David Geffen School of Medicine at UCLA; Director, UCLA Biopolymer Laboratory; and a member of the faculties of the Molecular Biology Institute, Brain Research Institute, Chemistry-Biology Interface Training Program, and various neuroscience graduate programs. Professor Teplow received degrees in Biochemistry, and in Bacteriology & Immunology, from UC Berkeley; a Ph.D. from the University of Washington, Seattle; and postdoctoral training at the California Institute of Technology, Pasadena, CA. From 1991-2005, Professor Teplow was a member of the faculty of the Department of Neurology, Harvard Medical School, Boston. Professor Teplow has published >200 peer-reviewed articles, including ~150 original articles and ~50 reviews, book chapters, and commentaries. Professor Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology. He currently is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease. Professor Teplow is a member of numerous national and international scientific advisory and editorial boards.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768640
Adroll
adroll